SEC Form 5 · accession 0001354488-16-006494
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terry Belmont
Director
Period of report
Dec 31, 2015
Accepted (ET)
Mar 9, 2016 · 10:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2015 | M | 4,000 | $5.50 | A | 4,000 | D | |
| Common Stock | Jun 15, 2015 | S | 4,000 | $37.82 | D | 0 | D | |
| Common StockF1 | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) (2013 Plan) | $15.62 | Nov 7, 2014 | A | 0 | A | Nov 7, 2015 | Nov 7, 2024 | Common Stock | 3,000 | 3,000 | D |
| Non-Qualified Stock Option (right to buy) (2013 Plan) | $12.94 | Dec 9, 2014 | A | 0 | A | Dec 9, 2015 | Dec 9, 2024 | Common Stock | 4,000 | 4,000 | D |
| Non-Qualified Stock Option (right to buy) (2013 Plan) | $5.50 | Jun 15, 2015 | M | 0 | D | Dec 9, 2014 | Dec 9, 2023 | Common Stock | 4,000 | 0 | D |
Explanation of responses
- F1On September 29, 2015, the reporting person transferred 2,224 shares of common stock of the issuer to his ex-wife pursuant to a court order issued in connection with a matrimonial proceeding.